244 related articles for article (PubMed ID: 27821401)
1. Comparison of Drug-Eluting and Bare Metal Stents in Patients With Chronic Kidney Disease: An Updated Systematic Review and Meta-Analysis.
Lu R; Tang F; Zhang Y; Zhu X; Zhu S; Wang G; Jiang Y; Fan Z
J Am Heart Assoc; 2016 Nov; 5(11):. PubMed ID: 27821401
[TBL] [Abstract][Full Text] [Related]
2. Drug-eluting stents versus bare-metal stents in patients with decreased GFR: a meta-analysis.
Wang ZJ; Harjai KJ; Shenoy C; Gao F; Shi DM; Liu YY; Zhao YX; Zhou YJ
Am J Kidney Dis; 2013 Oct; 62(4):711-21. PubMed ID: 23773369
[TBL] [Abstract][Full Text] [Related]
3. Meta-analysis of long-term outcomes for drug-eluting stents versus bare-metal stents in primary percutaneous coronary interventions for ST-segment elevation myocardial infarction.
Wallace EL; Abdel-Latif A; Charnigo R; Moliterno DJ; Brodie B; Matnani R; Ziada KM
Am J Cardiol; 2012 Apr; 109(7):932-40. PubMed ID: 22221949
[TBL] [Abstract][Full Text] [Related]
4. A comprehensive meta-analysis of randomized controlled trials comparing drug-eluting stents with bare-metal stents in saphenous vein graft interventions.
Shah R; Jovin IS; Latham SB; Hesterberg K; Heckle MR; Rashid A; Vetrovec GW
Catheter Cardiovasc Interv; 2018 Dec; 92(7):1229-1236. PubMed ID: 30051628
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and Safety of Drug-Eluting Stents Optimized for Biocompatibility vs Bare-Metal Stents With a Single Month of Dual Antiplatelet Therapy: A Meta-analysis.
Shah R; Rao SV; Latham SB; Kandzari DE
JAMA Cardiol; 2018 Nov; 3(11):1050-1059. PubMed ID: 30383145
[TBL] [Abstract][Full Text] [Related]
6. Long-term outcome of patients with very small coronary artery disease: A comparison of drug-eluting and bare metal stents.
Wang WT; Sung SH; Wu CH; Huang SS; Chen WL; Lin SJ; Lu TM
J Chin Med Assoc; 2016 Dec; 79(12):642-648. PubMed ID: 27692781
[TBL] [Abstract][Full Text] [Related]
7. The Role of Vascular Imaging in Guiding Routine Percutaneous Coronary Interventions: A Meta-Analysis of Bare Metal Stent and Drug-Eluting Stent Trials.
Alsidawi S; Effat M; Rahman S; Abdallah M; Leesar M
Cardiovasc Ther; 2015 Dec; 33(6):360-6. PubMed ID: 26363283
[TBL] [Abstract][Full Text] [Related]
8. Drug-eluting stents versus bare-metal stents for acute coronary syndrome.
Feinberg J; Nielsen EE; Greenhalgh J; Hounsome J; Sethi NJ; Safi S; Gluud C; Jakobsen JC
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD012481. PubMed ID: 28832903
[TBL] [Abstract][Full Text] [Related]
9. Drug-coated balloon versus drug-eluting stent in de novo small coronary vessel disease: A systematic review and meta-analysis.
Li M; Guo C; Lv YH; Zhang MB; Wang ZL
Medicine (Baltimore); 2019 May; 98(21):e15622. PubMed ID: 31124941
[TBL] [Abstract][Full Text] [Related]
10. Intravascular ultrasound to guide percutaneous coronary interventions: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2006; 6(12):1-97. PubMed ID: 23074482
[TBL] [Abstract][Full Text] [Related]
11. Drug-eluting stents for revascularization of infrapopliteal arteries: updated meta-analysis of randomized trials.
Fusaro M; Cassese S; Ndrepepa G; Tepe G; King L; Ott I; Nerad M; Schunkert H; Kastrati A
JACC Cardiovasc Interv; 2013 Dec; 6(12):1284-93. PubMed ID: 24355118
[TBL] [Abstract][Full Text] [Related]
12. Long-term outcome of percutaneous catheter intervention for de novo coronary bifurcation lesions with drug-eluting stents or bare-metal stents.
Ferenc M; Gick M; Kienzle RP; Bestehorn HP; Werner KD; Comberg T; Zhao M; Buettner HJ; Neumann FJ
Am Heart J; 2010 Mar; 159(3):454-61. PubMed ID: 20211309
[TBL] [Abstract][Full Text] [Related]
13. Can Platforms Affect the Safety and Efficacy of Drug-Eluting Stents in the Era of Biodegradable Polymers?: A Meta-Analysis of 34,850 Randomized Individuals.
Yan YF; Jiang L; Zhang MD; Li XH; Nie MX; Feng TT; Zhao X; Wang LY; Zhao QM
PLoS One; 2016; 11(3):e0151259. PubMed ID: 27032086
[TBL] [Abstract][Full Text] [Related]
14. Drug-Eluting Versus Bare Metal Stents in Saphenous Vein Graft Intervention: An Updated Comprehensive Meta-Analysis of Randomized Trials.
Bhogal S; Panchal HB; Bagai J; Banerjee S; Brilakis ES; Mukherjee D; Kumar G; Shanmugasundaram M; Paul TK
Cardiovasc Revasc Med; 2019 Sep; 20(9):758-767. PubMed ID: 30503811
[TBL] [Abstract][Full Text] [Related]
15. Stent thrombosis with second-generation drug-eluting stents compared with bare-metal stents: network meta-analysis of primary percutaneous coronary intervention trials in ST-segment–elevation myocardial infarction [corrected].
Philip F; Agarwal S; Bunte MC; Goel SS; Tuzcu EM; Ellis S; Kapadia SR
Circ Cardiovasc Interv; 2014 Feb; 7(1):49-61. PubMed ID: 24280964
[TBL] [Abstract][Full Text] [Related]
16. Comparison of newer-generation drug-eluting with bare-metal stents in patients with acute ST-segment elevation myocardial infarction: a pooled analysis of the EXAMINATION (clinical Evaluation of the Xience-V stent in Acute Myocardial INfArcTION) and COMFORTABLE-AMI (Comparison of Biolimus Eluted From an Erodible Stent Coating With Bare Metal Stents in Acute ST-Elevation Myocardial Infarction) trials.
Sabaté M; Räber L; Heg D; Brugaletta S; Kelbaek H; Cequier A; Ostojic M; Iñiguez A; Tüller D; Serra A; Baumbach A; von Birgelen C; Hernandez-Antolin R; Roffi M; Mainar V; Valgimigli M; Serruys PW; Jüni P; Windecker S
JACC Cardiovasc Interv; 2014 Jan; 7(1):55-63. PubMed ID: 24332419
[TBL] [Abstract][Full Text] [Related]
17. Meta-analysis of randomized trials of drug-eluting stents versus bare metal stents in patients with diabetes mellitus.
Boyden TF; Nallamothu BK; Moscucci M; Chan PS; Grossman PM; Tsai TT; Chetcuti SJ; Bates ER; Gurm HS
Am J Cardiol; 2007 May; 99(10):1399-402. PubMed ID: 17493468
[TBL] [Abstract][Full Text] [Related]
18. Comparison of drug-eluting and bare-metal stents in patients with diabetes undergoing primary percutaneous coronary intervention: what is the evidence?
Gollop ND; Henderson DB; Flather MD
Interact Cardiovasc Thorac Surg; 2014 Jan; 18(1):112-6. PubMed ID: 24144807
[TBL] [Abstract][Full Text] [Related]
19. Short- and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison analysis of 117 762 patient-years of follow-up from randomized trials.
Bangalore S; Kumar S; Fusaro M; Amoroso N; Attubato MJ; Feit F; Bhatt DL; Slater J
Circulation; 2012 Jun; 125(23):2873-91. PubMed ID: 22586281
[TBL] [Abstract][Full Text] [Related]
20. Meta-analysis comparison (nine trials) of outcomes with drug-eluting stents versus bare metal stents in patients with diabetes mellitus.
Patti G; Nusca A; Di Sciascio G
Am J Cardiol; 2008 Nov; 102(10):1328-34. PubMed ID: 18993150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]